Ananda Scientific News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ANANDA Scientific Inc., a research focused bio-pharmaceutical company today announced that the first subject has been enrolled in the clinical trial with an FDA-approved IND evaluating Nantheia™ A1002N5S, an investigational drug using cannabidiol (CBD) in ANANDA’s proprietary Liquid Structure™ delivery technology as a potential treatment for Social Anxiety Disorder (SAD).

GREENWOOD VILLAGE, Colo. and LOS ANGELES, July 26, 2022 /PRNewswire/ -- ANANDA Scientific Inc., a research focused bio-pharmaceutical company today announced the first patient enrolled in the

Ananda Scientific announced a collaboration with University of Nebraska Medical Center on a post-traumatic stress disorder (PTSD) treatment.

Ananda Scientific says it has been approved by the FDA to kick off a clinical trial evaluating CBD in treating Opioid Use Disorder.

/PRNewswire/ -- According to the Coherent Market Insights, The global cannabidiol market is estimated to account for 55,200.2 Mn in terms of value by the end...